0001179110-17-009169.txt : 20170616
0001179110-17-009169.hdr.sgml : 20170616
20170616093219
ACCESSION NUMBER: 0001179110-17-009169
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170615
FILED AS OF DATE: 20170616
DATE AS OF CHANGE: 20170616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celldex Therapeutics, Inc.
CENTRAL INDEX KEY: 0000744218
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 133191702
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
BUSINESS PHONE: 908-200-7500
MAIL ADDRESS:
STREET 1: 53 FRONTAGE ROAD
STREET 2: SUITE 220
CITY: HAMPTON
STATE: NJ
ZIP: 08827
FORMER COMPANY:
FORMER CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19980828
FORMER COMPANY:
FORMER CONFORMED NAME: T CELL SCIENCES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brownlie Keith L
CENTRAL INDEX KEY: 0001518575
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15006
FILM NUMBER: 17914951
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgar.xml
FORM 4 -
X0306
4
2017-06-15
0
0000744218
Celldex Therapeutics, Inc.
CLDX
0001518575
Brownlie Keith L
C/O CELLDEX THERAPEUTICS, INC.
53 FRONTAGE ROAD, SUITE 220
HAMPTON
NJ
08827
1
0
0
0
Common Stock, par value $0.001 per share
2017-06-15
4
A
0
10000
A
10000
D
Non-Qualified Stock Option (right to buy)
2.32
2017-06-15
4
A
0
15000
0
A
2018-06-15
2027-06-15
Common Stock
15000
15000
D
Non-Qualified Stock Option (right to buy)
2.32
2017-06-15
4
A
0
8000
0
A
2018-06-15
2027-06-15
Common Stock
8000
8000
D
On June 15, 2017, the Company awarded 10,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan subject to time-based forfeiture restrictions.
Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
Such option vests in three equal annual installments beginning June 15, 2018.
100% of the total amount of shares subject to the Option vests on June 15, 2018.
/s/ Avery W. Catlin, attorney-in-fact for Keith L. Brownlie
2017-06-16